Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Private equity owner of Dr. Squatch explores $2 bln-plus sale of personal care brand, sources say

Wed, 03rd Apr 2024 21:20

NEW YORK, April 3 (Reuters) - The private equity owner of Dr. Squatch is exploring a sale of the men's grooming brand that it hopes will value the company at more than $2 billion, people familiar with the matter said on Wednesday.

The company, which is majority-owned by Summit Partners, is working with investment banks Raymond James and Centerview Partners to gauge interest from potential buyers, the sources said, requesting anonymity as the discussions are confidential.

Dr. Squatch currently generates 12-month earnings before interest, taxes, depreciation and amortization (EBITDA) of about $90 million and is growing rapidly, the sources said.

Dr. Squatch, Summit Partners, and Raymond James did not immediately respond to requests for comment. Centerview declined to comment.

Launched in 2013 by founder and CEO Jack Haldrup and named after the mythical creature Sasquatch, Dr. Squatch started out by selling handmade bar soaps for men. Haldrup created his own soap flavors out of his garage because natural soap for men is not widely produced by major personal care brands.

The Los Angeles-based company currently sells deodorant, hair care products, colognes, lotions and other personal care products through its website and at brick-and-mortar stores like Walmart and Target.

Dr. Squatch is known for its Super Bowl ads targeting men and unique scents like cold brew cleanse and grapefruit IPA.

The personal care segment has been a bright spot for dealmaking over the past year. Carlyle-owned grooming brand Every Man Jack has been exploring a sale, while Unilever agreed to sell one of its men's personal care brands, Dollar Shave Club, to private-equity firm Nexus Capital Management last year. (Reporting by Abigail Summerville and Anirban Sen in New York; editing by Diane Craft)

Walmart Target Corp Unilever Raymond James Financial

Shares in this article

Related News

UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh
3 days ago

UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh

May 1 (Reuters) - London's blue-chip FTSE 100 closed slightly lower on ​Friday, ‌dragged down by losses in heavyweight energy stocks and drugmaker Ast...

Market News Astrazeneca + 7 more shares
WINNERS & LOSERS: Pearson and NatWest diverge after updates
4 days ago

WINNERS & LOSERS: Pearson and NatWest diverge after updates

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

Risers and Fallers Pearson + 20 more shares
Berenberg lowers target price on Unilever
4 days ago

Berenberg lowers target price on Unilever

(Sharecast News) - Berenberg lowered its target price on consumer goods giant Unilever from £58.40 to £50.40 on Friday following the group's...